Ricerca, LLC Announces New Appointments

Apr 10, 2001, 01:00 ET from Ricerca, LLC

    CONCORD, Ohio, April 10 /PRNewswire/ -- Ricerca, LLC, a drug development
 company, has made the following appointments to enhance its unique position in
 applying advanced chemistry and safety assessment expertise to early
 confirmation of the safety and utility of new drug candidates: Anthony O.
 Chong, Ph.D., to vice president, process chemistry; Thomas J. Doran, Ph.D., to
 vice president, metabolism; Larry J. Powers, Ph.D., to vice president,
 analytical & medicinal chemistry; Walter E. Stalzer, P.E., to vice president,
 process development & engineering; and Michael Watson to vice president,
 toxicology & pharmacology.
     "Today, the pharmaceutical industry is faced with a large number of
 targets and drug leads from genomics, high throughput screening and
 combinatorial chemistry efforts," said Dr. Prabhavathi Fernandes, Ricerca CEO.
 "For our drug development clients, every day saved translates into significant
 product dollars.  This new optimized organizational structure for providing
 drug development helps us provide value to our clients right from the
 beginning of our relationships by streamlining the process."
     Ricerca, LLC, a drug development company, offers technical expertise in
 late stage discovery through IND development.  The company speeds drug lead
 optimization and preclinical candidate selection through advanced Absorption,
 Distribution, Metabolism, Excretion and Toxicology (ADMET) technologies, and
 then helps its customers rapidly develop the preclinical Chemistry,
 Manufacturing and Controls (CMC) and nonclinical safety data to support filing
 of the Investigational New Drug application (IND).  When the drug enters human
 clinical investigations, Ricerca provides continued critical chemical process
 development and optimization, API production and clinical trial sample
 bioanalysis.  The company, privately owned by SG Capital Partners, LLC, New
 York, NY and Venture Biologics, LLC, Plymouth Meeting, PA is located near
 Cleveland, Ohio and has over 240 employees.
 
 

SOURCE Ricerca, LLC
    CONCORD, Ohio, April 10 /PRNewswire/ -- Ricerca, LLC, a drug development
 company, has made the following appointments to enhance its unique position in
 applying advanced chemistry and safety assessment expertise to early
 confirmation of the safety and utility of new drug candidates: Anthony O.
 Chong, Ph.D., to vice president, process chemistry; Thomas J. Doran, Ph.D., to
 vice president, metabolism; Larry J. Powers, Ph.D., to vice president,
 analytical & medicinal chemistry; Walter E. Stalzer, P.E., to vice president,
 process development & engineering; and Michael Watson to vice president,
 toxicology & pharmacology.
     "Today, the pharmaceutical industry is faced with a large number of
 targets and drug leads from genomics, high throughput screening and
 combinatorial chemistry efforts," said Dr. Prabhavathi Fernandes, Ricerca CEO.
 "For our drug development clients, every day saved translates into significant
 product dollars.  This new optimized organizational structure for providing
 drug development helps us provide value to our clients right from the
 beginning of our relationships by streamlining the process."
     Ricerca, LLC, a drug development company, offers technical expertise in
 late stage discovery through IND development.  The company speeds drug lead
 optimization and preclinical candidate selection through advanced Absorption,
 Distribution, Metabolism, Excretion and Toxicology (ADMET) technologies, and
 then helps its customers rapidly develop the preclinical Chemistry,
 Manufacturing and Controls (CMC) and nonclinical safety data to support filing
 of the Investigational New Drug application (IND).  When the drug enters human
 clinical investigations, Ricerca provides continued critical chemical process
 development and optimization, API production and clinical trial sample
 bioanalysis.  The company, privately owned by SG Capital Partners, LLC, New
 York, NY and Venture Biologics, LLC, Plymouth Meeting, PA is located near
 Cleveland, Ohio and has over 240 employees.
 
 SOURCE  Ricerca, LLC